Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus immediate-release to prolonged-release conversion variability study in stable kidney transplant recipients
NL-OMON35391Not yet recruiting
- Sponsor
- Maastricht University Medical Center+
- Start
- Jun 2009
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of tacrolimus in kidney transplant, sponsored by Maastricht University Medical Center+. Primary endpoint: Intra- and interpatient variability of tacrolimus AUC. Planned start Jun 2009; status: not yet recruiting.
02
Drugs
tacrolimus
03
Conditions
kidney transplant
Beyond the preview
Go deeper on NL-OMON35391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON35391.